The aims of this study were to create a copy number variant (CNV) profile of human chromosome 22 and to establish a genotype-phenotype correlation for patients with genomic abnormalities on chromosome 22. Thus, 1,654 consecutive pediatric patients with a diversity of clinical findings were evaluated by high-resolution chromosomal microarray analysis (CMA). We identified 25 individuals with abnormal CNVs on chromosome 22, representing 1.5% of the cases analyzed in this cohort. Meanwhile, we detected 1,298 benign CNVs on this chromosome in these individuals. Twenty-one of the 25 abnormal CNVs and the majority of the benign CNVs occurred through involvement of the 8 unstable genomic regions enriched with low copy repeats (LCR22A–H). The highly dynamic status of LCR22s within the 22q11 region facilitates the formation of diverse genomic abnormalities. This CNV profile provides a general perspective of the spectrum of chromosome 22 genomic imbalances and subsequently improves the CNV-phenotype correlations.

Keywords:
Chromosomal microarray analysis, Chromosome 22, Copy number variant, Deletion, Duplication, Genomic disorders, Low copy repeat
1.
Abo-Dalo B, Kutsche K, Mautner V, Kluwe L: Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes. Genes Chromosomes Cancer 49:171–175 (2010).
2.
Ballif BC, Yu W, Shaw CA, Kashork CD, Shaffer LG: Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions. Hum Mol Genet 12:2153–2165 (2003).
3.
Ballif BC, Hornor SA, Jenkins E, Madan-Khetarpal S, Surti U, et al: Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 39:1071–1073 (2007).
4.
Belien V, Gerard-Blanluet M, Serero S, Le Du N, Baumann C, et al: Partial trisomy of chromosome 22 resulting from a supernumerary marker chromosome 22 in a child with features of cat eye syndrome. Am J Med Genet A 146A:1871–1874 (2008).
5.
Ben-Shachar S, Ou Z, Shaw CA, Belmont JW, Patel MS, et al: 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 82:214–221 (2008).
6.
Berends MJ, Tan-Sindhunata G, Leegte B, van Essen AJ: Phenotypic variability of cat-eye syndrome. Genet Couns 12:23–34 (2001).
7.
Berg JS, Potocki L, Bacino CA: Common recurrent microduplication syndromes: diagnosis and management in clinical practice. Am J Med Genet A 152A:1066–1078 (2010).
8.
Bittel DC, Yu S, Newkirk H, Kibiryeva N, Holt A 3rd, et al: Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res 124:113–120 (2009).
9.
Brunet A, Armengol L, Heine D, Rosell J, Garcia-Aragones M, et al: BAC array CGH in patients with velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1. BMC Med Genet 10:144 (2009).
10.
Cole CG, McCann OT, Collins JE, Oliver K, Willey D, et al: Finishing the finished human chromosome 22 sequence. Genome Biol 9:R78 (2008).
11.
Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, et al: Origins and functional impact of copy number variation in the human genome. Nature 464:704–712 (2009).
12.
Coppinger J, McDonald-McGinn D, Zackai E, Shane K, Atkin JF, et al: Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region. Hum Mol Genet 18:1377–1383 (2009).
13.
D’Angelo CS, Jehee FS, Koiffmann CP: An inherited atypical 1 Mb 22q11.2 deletion within the DGS/VCFS 3 Mb region in a child with obesity and aggressive behavior. Am J Med Genet A 143A:1928–1932 (2007).
14.
Descartes M, Franklin J, de Stahl TD, Piotrowski A, Bruder CE, et al: Distal 22q11.2 microduplication encompassing the BCR gene. Am J Med Genet A 146A:3075–3081 (2008).
15.
de Smith AJ, Walters RG, Coin LJ, Steinfeld I, Yakhini Z, et al: Small deletion variants have stable breakpoints commonly associated with Alu elements. PLoS One 3:e3104 (2008).
16.
Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, et al: The DNA sequence of human chromosome 22. Nature 402:489–495 (1999).
17.
Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, et al: Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 73:1027–1040 (2003).
18.
Fernandez L, Nevado J, Santos F, Heine-Suner D, Martinez-Glez V, et al: A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Med Genet 10:48 (2009).
19.
Foley P, Bunyan D, Stratton J, Dillon M, Lynch SA: Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. Am J Med Genet A 149A:997–1000 (2009).
20.
Gauthier J, Spiegelman D, Piton A, Lafreniere RG, Laurent S, et al: Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet 150B:421–424 (2009).
21.
Gothelf D, Frisch A, Michaelovsky E, Weizman A, Shprintzen RJ: Velo-cardio-facial syndrome. J Ment Health Res Intellect Disabil 2:149–167 (2009).
22.
Gu W, Zhang F, Lupski JR: Mechanisms for human genomic rearrangements. Pathogenetics 1:4 (2008).
23.
Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, et al: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947–956 (2009).
24.
Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A: Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27:293–298 (2001).
25.
Guris DL, Duester G, Papaioannou VE, Imamoto A: Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell 10:81–92 (2006).
26.
Hannes F, Vermeesch JR: Benign and pathogenic copy number variation on the short arm of chromosome 4. Cytogenet Genome Res 123:88–93 (2008).
27.
Hastings PJ, Ira G, Lupski JR: A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327 (2009).
28.
Hierck BP, Molin DG, Boot MJ, Poelmann RE, Gittenberger-de Groot AC: A chicken model for DGCR6 as a modifier gene in the DiGeorge critical region. Pediatr Res 56:440–448 (2004).
29.
Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, et al: High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 122:117–127 (2007).
30.
Kidd JM, Graves T, Newman TL, Fulton R, Hayden HS, et al: A human genome structural variation sequencing resource reveals insights into mutational mechanisms. Cell 143:837–847 (2010).
31.
Koolen DA, Reardon W, Rosser EM, Lacombe D, Hurst JA, et al: Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation. Eur J Hum Genet 13:1019–1024 (2005).
32.
Kurahashi H, Tsuda E, Kohama R, Nakayama T, Masuno M, et al: Another critical region for deletion of 22q11: a study of 100 patients. Am J Med Genet 72:180–185 (1997).
33.
Lafay-Cousin L, Payne E, Strother D, Chernos J, Chan M, Bernier FP: Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor. Am J Med Genet A 149A:2855–2859 (2009).
34.
Lee C, Iafrate AJ, Brothman AR: Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 39:S48–S54 (2007).
35.
Liehr T, Mrasek K, Weise A, Dufke A, Rodriguez L, et al: Small supernumerary marker chromosomes – progress towards a genotype-phenotype correlation. Cytogenet Genome Res 112:23–34 (2006).
36.
Luciani JJ, de Mas P, Depetris D, Mignon-Ravix C, Bottani A, et al: Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet 40:690–696 (2003).
37.
Lupski JR: Structural variation in the human genome. N Engl J Med 356:1169–1171 (2007).
38.
Makoff AJ, Flomen RH: Detailed analysis of 15q11-q14 sequence corrects errors and gaps in the public access sequence to fully reveal large segmental duplications at breakpoints for Prader-Willi, Angelman, and inv dup(15) syndromes. Genome Biol 8:R114 (2007).
39.
Masukawa H, Ozaki T, Nogimori T: Cat eye syndrome with hypogonadotropic hypogonadism. Intern Med 37:853–856 (1998).
40.
McDermid HE, Morrow BE: Genomic disorders on 22q11. Am J Hum Genet 70:1077–1088 (2002).
41.
Mefford HC, Eichler EE: Duplication hotspots, rare genomic disorders, and common disease. Curr Opin Genet Dev 19:196–204 (2009).
42.
Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, et al: Mapping copy number variation by population-scale genome sequencing. Nature 470:59–65 (2011).
43.
Pfuhl T, Durr M, Spurk A, Schwalbert B, Nord R, et al: Biochemical characterisation of the proteins encoded by the DiGeorge critical region 6 (DGCR6) genes. Hum Genet 117:70–80 (2005).
44.
Phelan MC: Deletion 22q13.3 syndrome. Orphanet J Rare Dis 3:14 (2008).
45.
Portnoï MF: Microduplication 22q11.2: a new chromosomal syndrome. Eur J Med Genet 52:88–93 (2009).
46.
Samuels IS, Saitta SC, Landreth GE: MAP’ing CNS development and cognition: an ERKsome process. Neuron 61:160–167 (2009).
47.
Shaikh TH, O’Connor RJ, Pierpont ME, McGrath J, Hacker AM, et al: Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms. Genome Res 17:482–491 (2007).
48.
Trabacca A, Losito L, De Rinaldis M, Gennaro L: Congenital hypotonia in a child with a de novo 22q13 monosomy and 2pter duplication: a clinical and molecular genetic study. J Child Neurol 26:235–238 (2011).
49.
Willis A, Bender HU, Steel G, Valle D: PRODH variants and risk for schizophrenia. Amino Acids 35:673–679 (2008).
50.
Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, et al: Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 40:575–584 (2003).
51.
Yu S, Bittel DC, Kibiryeva N, Zwick DL, Cooley LD: Validation of the Agilent 244K oligonucleotide array-based comparative genomic hybridization platform for clinical cytogenetic diagnosis. Am J Clin Pathol 132:349–360 (2009a).
52.
Yu S, Kielt M, Stegner AL, Kibiryeva N, Bittel DC, Cooley LD: Quantitative real-time polymerase chain reaction for the verification of genomic imbalances detected by microarray-based comparative genomic hybridization. Genet Test Mol Biomarkers 13:751–760 (2009b).
53.
Yu S, Fiedler S, Stegner A, Graf WD: Genomic profile of copy number variants on the short arm of human chromosome 8. Eur J Hum Genet 18:1114–1120 (2010).
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.